このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Shree Ram Proteins 過去の業績

過去基準チェック /06

Shree Ram Proteinsの収益は年間平均-18.6%の割合で減少していますが、 Food業界の収益は年間増加しています。収益は年間15% 3.4%割合で減少しています。

主要情報

-31.0%

収益成長率

-30.5%

EPS成長率

Food 業界の成長	17.6%
収益成長率	-9.1%
株主資本利益率	-22.1%
ネット・マージン	-181.8%
前回の決算情報	30 Jun 2024

Recent updates

These 4 Measures Indicate That Shree Ram Proteins (NSE:SRPL) Is Using Debt Extensively

Feb 28

These 4 Measures Indicate That Shree Ram Proteins (NSE:SRPL) Is Using Debt Reasonably Well

Mar 29

Calculating The Fair Value Of Shree Ram Proteins Limited (NSE:SRPL)

Dec 11

Shree Ram Proteins (NSE:SRPL) Seems To Use Debt Quite Sensibly

Nov 06

These 4 Measures Indicate That Shree Ram Proteins (NSE:SRPL) Is Using Debt Extensively

Jun 19

Here's Why Shree Ram Proteins (NSE:SRPL) Has A Meaningful Debt Burden

Feb 24

収支内訳

Shree Ram Proteins の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

NSEI:SRPL 収益、費用、利益 ( )INR Millions
日付	収益	収益	G+A経費
30 Jun 24	57	-103	5
31 Mar 24	148	-96	7
31 Dec 23	391	-53	10
30 Sep 23	768	-2	12
30 Jun 23	1,195	27	14
31 Mar 23	1,627	38	15
31 Dec 22	2,367	52	19
30 Sep 22	2,688	59	18
30 Jun 22	3,012	65	18
31 Mar 22	2,878	61	16
31 Dec 21	2,699	79	12
30 Sep 21	2,527	64	11
30 Jun 21	1,817	33	12
31 Mar 21	1,526	8	11
31 Dec 20	1,468	-11	9
30 Sep 20	1,248	-13	9
30 Jun 20	1,404	7	10
31 Mar 20	1,559	26	10
31 Dec 19	1,273	19	9
30 Sep 19	1,429	38	10
30 Jun 19	1,505	36	9
31 Mar 19	1,581	33	8
31 Dec 18	1,853	26	7
30 Sep 18	2,127	19	6
30 Jun 18	2,040	19	5
31 Mar 18	1,954	18	5
31 Mar 17	1,574	6	3
31 Mar 16	1,833	5	4
31 Mar 15	1,744	14	4
31 Mar 14	1,573	13	2

質の高い収益: SRPLは現在利益が出ていません。

利益率の向上: SRPLは現在利益が出ていません。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: SRPLは利益が出ておらず、過去 5 年間で損失は年間18.6%の割合で増加しています。

成長の加速: SRPLの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: SRPLは利益が出ていないため、過去 1 年間の収益成長をFood業界 ( 15% ) と比較することは困難です。

株主資本利益率

高いROE: SRPLは現在利益が出ていないため、自己資本利益率 ( -20.62% ) はマイナスです。

Shree Ram Proteins 過去の業績

過去 基準チェック /06

主要情報

最近の業績更新

First quarter 2025 earnings released: ₹0.02 loss per share (vs ₹0.01 profit in 1Q 2024)

Full year 2024 earnings released: ₹0.45 loss per share (vs ₹0.18 profit in FY 2023)

Second quarter 2024 earnings released: ₹0.09 loss per share (vs ₹0.048 profit in 2Q 2023)

Shree Ram Proteins Limited to Report Q2, 2024 Results on Nov 08, 2023

Full year 2023 earnings released: EPS: ₹0.18 (vs ₹0.29 in FY 2022)

Full year 2023 earnings released: EPS: ₹1.79 (vs ₹2.87 in FY 2022)

Recent updates

First quarter 2025 earnings released: ₹0.02 loss per share (vs ₹0.01 profit in 1Q 2024)

Full year 2024 earnings released: ₹0.45 loss per share (vs ₹0.18 profit in FY 2023)

New minor risk - Share price stability

New major risk - Revenue and earnings growth

Now 22% overvalued after recent price rise

Now 24% overvalued after recent price rise

These 4 Measures Indicate That Shree Ram Proteins (NSE:SRPL) Is Using Debt Extensively

Less than half of directors are independent

Shree Ram Proteins Limited Announces the Resignation of Jaykumar Deepakbhai Khatnani as Independent Director

New minor risk - Share price stability

Second quarter 2024 earnings released: ₹0.09 loss per share (vs ₹0.048 profit in 2Q 2023)

Shree Ram Proteins Limited to Report Q2, 2024 Results on Nov 08, 2023

Investor sentiment deteriorates as stock falls 15%

Investor sentiment improves as stock rises 16%

Shree Ram Proteins Limited, Annual General Meeting, Aug 14, 2023

Is Shree Ram Proteins (NSE:SRPL) A Risky Investment?

Less than half of directors are independent

Full year 2023 earnings released: EPS: ₹0.18 (vs ₹0.29 in FY 2022)

Investor sentiment deteriorates as stock falls 16%

Investor sentiment deteriorates as stock falls 15%

Investor sentiment improves as stock rises 17%

Full year 2023 earnings released: EPS: ₹1.79 (vs ₹2.87 in FY 2022)

Investor sentiment improves as stock rises 16%

Chairman & MD recently sold ₹15m worth of stock

Chairman & MD recently sold ₹22m worth of stock

Shree Ram Proteins (NSE:SRPL) Has A Pretty Healthy Balance Sheet

Investor sentiment deteriorates as stock falls 17%

Chairman & MD recently sold ₹4.9m worth of stock

Third quarter 2023 earnings released: EPS: ₹0.25 (vs ₹0.56 in 3Q 2022)

Chairman & MD recently sold ₹2.0m worth of stock

Investor sentiment deteriorated over the past week

Non Executive Director recently sold ₹7.3m worth of stock

Non Executive Director recently bought ₹40m worth of stock

Insider recently sold ₹2.4m worth of stock

Is Shree Ram Proteins (NSE:SRPL) A Risky Investment?

Investor sentiment improved over the past week

Insider recently sold ₹1.7m worth of stock

Chairman & MD recently bought ₹2.4m worth of stock

Second quarter 2023 earnings released: EPS: ₹0.48 (vs ₹0.77 in 2Q 2022)

Less than half of directors are independent

Chairman & MD recently bought ₹1.6m worth of stock

Investor sentiment deteriorated over the past week

Promoter & Whole-Time Director recently sold ₹10m worth of stock

Promoter & Whole-Time Director recently sold ₹3.2m worth of stock

Promoter & Whole-Time Director recently sold ₹2.8m worth of stock

Investor sentiment deteriorated over the past week

Shree Ram Proteins Limited, Annual General Meeting, Jul 18, 2022

Does Shree Ram Proteins (NSE:SRPL) Have A Healthy Balance Sheet?

Promoter & Whole-Time Director recently sold ₹11m worth of stock

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Chairman & MD recently sold ₹4.5m worth of stock

Investor sentiment deteriorated over the past week

Chairman & MD recently sold ₹2.8m worth of stock

Full year 2022 earnings released: EPS: ₹2.87 (vs ₹0.39 in FY 2021)

Chairman & MD recently sold ₹3.7m worth of stock

These 4 Measures Indicate That Shree Ram Proteins (NSE:SRPL) Is Using Debt Reasonably Well

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Calculating The Fair Value Of Shree Ram Proteins Limited (NSE:SRPL)

Investor sentiment improved over the past week

Shree Ram Proteins (NSE:SRPL) Seems To Use Debt Quite Sensibly

Second quarter 2022 earnings released: EPS ₹0.77 (vs ₹1.27 loss in 2Q 2021)

These 4 Measures Indicate That Shree Ram Proteins (NSE:SRPL) Is Using Debt Extensively

Full year 2021 earnings released: EPS ₹0.39 (vs ₹1.22 in FY 2020)

Here's Why Shree Ram Proteins (NSE:SRPL) Has A Meaningful Debt Burden

Third quarter 2021 earnings released: ₹0.16 loss per share (vs ₹0.22 loss in 3Q 2020)

New 90-day high: ₹37.35

Shree Ram Proteins Limited Announces Board Changes

過去基準チェック /06